About this Journal Submit a Manuscript Table of Contents
Case Reports in Hematology
Volume 2012 (2012), Article ID 589718, 3 pages
http://dx.doi.org/10.1155/2012/589718
Case Report

Hearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia

1Division of Hematology, The Arthur G. James Comprehensive Cancer Center and The Ohio State University, 320 W 10th Avenue, B354 Starling Loving Hall, Columbus, OH 43210, USA
2Department of Neurosurgery, The Arthur G. James Comprehensive Cancer Center and The Ohio State University, Columbus, OH 43210, USA

Received 27 September 2012; Accepted 16 October 2012

Academic Editors: M. Gentile and S. Storti

Copyright © 2012 Jonathon B. Cohen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Barcos, W. Lane, and G. A. Gomez, “An atuopsy study of 1206 acute and chronic leukemias (1958 to 1982),” Cancer, vol. 60, no. 4, pp. 827–837, 1987. View at Scopus
  2. C. P. E. Lange, R. E. Brouwer, R. Brooimans, and C. J. Vecht, “Leptomeningeal disease in chronic lymphocytic leukemia,” Clinical Neurology and Neurosurgery, vol. 109, no. 10, pp. 896–901, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. A. Moazzam, J. Drappatz, R. Y. Kim, and S. Kesari, “Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review,” Journal of Neuro-Oncology, vol. 106, no. 1, pp. 1–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Castro, D. F. James, J. D. Sandoval-Sus et al., “Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia,” Leukemia, vol. 23, no. 10, pp. 1779–1789, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Robak, P. Smolewski, B. Cebula, A. Szmigielska-Kaplon, K. Chojnowski, and J. Z. Blonski, “Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma,” Cancer, vol. 107, no. 7, pp. 1542–1550, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Robak, P. Smolewski, B. Cebula, O. Grzybowska-Izydorczyk, and J. Z. Błoński, “Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia,” European Journal of Haematology, vol. 79, no. 2, pp. 107–113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. H. Tonino, A. L. Rijssenbeek, M. E. Oud, et al., “Intracerebreal infilitration as the unique cause of the clinical presentation of chronic lymphocytic leukemia/small lymphocytic leukemia,” Journal of Clinical Oncology, vol. 29, pp. e837–e839, 2011.
  8. O. Akintola-Ogunremi, C. Whitney, S. C. Mathur, and C. N. Finch, “Chronic lymphocytic leukemia presenting with symptomatic central nervous system involvement,” Annals of Hematology, vol. 81, no. 7, pp. 402–404, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. M. C. J. Hanse, M. B. van't Veer, K. van Lom, and M. J. van den Bent, “Incidence of central nervous system involvement in chronic lymphocytic leukemia and outcome to treatment,” Journal of Neurology, vol. 255, no. 6, pp. 828–830, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Calvo-Villas, J. A. Fernandez, R. Fernandez, et al., “Intrathecal liposomal cytarabine (DepoCyte(R)) for treatment of leptomeningeal involvement from transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukemia (B-CLL) in Spain: report of 8 cases,” in Proceedings of the ASH Annual Meeting, vol. 114, p. 4411, 2009.